Freestone Grove Partners »

Cytomx Therapeutics shares owned by Freestone Grove Partners

Quarter-by-quarter ownership of Cytomx Therapeutics (CTMX) shares owned by Freestone Grove Partners from 13F filings

Historical chart of Freestone Grove Partners investment in Cytomx Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cytomx Therapeutics held by Freestone Grove Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytomx Therapeutics by Freestone Grove Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $71k 19k 3.75

More positions owned by Freestone Grove Partners

Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Us Bancorp Com New (USB)
Raytheon Technologies Corp (RTX)
Ge Aerospace Com New (GE)
Crane Company Common Stock (CR)
American Intl Group Com New (AIG)
Snowflake Com Shs (SNOW)
Fortune Brands (FBIN)
Johnson & Johnson (JNJ)
Abbott Laboratories (ABT)
Axis Cap Hldgs SHS (AXS)
Keurig Dr Pepper (KDP)
Microsoft Corporation (MSFT)

View all positions for Freestone Grove Partners

Top funds holding Cytomx Therapeutics

FMR
Kynam Capital Management
BlackRock
Bank of America Corporation
Perceptive Advisors
Vanguard Capital Management
Point72 Asset Management
State Street Corporation
Wellington Management Company
VR Adviser
Baker Bros. Advisors
Geode Capital Management
Elmind Capital
Nextech Invest
Two Sigma Investments

View all funds holding Cytomx Therapeutics